The Precision Peptide Genetic Test from PlexusDx identifies how your body responds to GLP-1 pathways by examining variants in genes like GIPR, which influence receptor sensitivity and medication effectiveness
Worth flagging to your physician
In 2009, Richard DiMarchi and Matthias H Tschp's team reported that dual agonists targeting GLP-1R/GCGR did better in weight loss compared to GLP-1RA [10]
This isn't a promise, but it was my experience
If you have insurance through Aetna, Trulicity is often covered, but coverage varies by specific plan, and additional limitations like prior authorization may apply
The direction is clear: more oral options, more receptors engaged per molecule, and broader supply